Electromed (NYSE:ELMD) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of Electromed (NYSE:ELMDFree Report) from a buy rating to a hold rating in a research note published on Monday.

Electromed Stock Performance

Shares of ELMD stock opened at $10.05 on Monday. Electromed has a 52 week low of $8.80 and a 52 week high of $13.84. The company’s 50 day moving average price is $10.42 and its two-hundred day moving average price is $10.46. The company has a market capitalization of $86.23 million, a P/E ratio of 27.16 and a beta of 0.30.

Institutional Investors Weigh In On Electromed

Institutional investors have recently added to or reduced their stakes in the stock. Hunter Associates Investment Management LLC raised its stake in shares of Electromed by 2.7% in the 2nd quarter. Hunter Associates Investment Management LLC now owns 75,500 shares of the company’s stock valued at $810,000 after purchasing an additional 2,000 shares during the period. Punch & Associates Investment Management Inc. lifted its stake in Electromed by 0.3% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 418,896 shares of the company’s stock valued at $4,352,000 after acquiring an additional 1,431 shares in the last quarter. Riverwater Partners LLC boosted its position in Electromed by 83.5% during the 3rd quarter. Riverwater Partners LLC now owns 32,684 shares of the company’s stock worth $340,000 after acquiring an additional 14,871 shares during the last quarter. Royal Bank of Canada grew its stake in shares of Electromed by 1.0% during the 3rd quarter. Royal Bank of Canada now owns 100,586 shares of the company’s stock worth $1,031,000 after acquiring an additional 1,030 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Electromed by 13.9% during the 2nd quarter. Geode Capital Management LLC now owns 60,435 shares of the company’s stock worth $647,000 after acquiring an additional 7,359 shares in the last quarter. 26.67% of the stock is owned by institutional investors.

About Electromed

(Get Free Report)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

Featured Articles

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.